Summit Therapeutics logo

SUMM - Summit Therapeutics Share Price

20.5p 0.0  0.0%

Last Trade - 21/02/20

Sector
Healthcare
Size
Small Cap
Market Cap £68.9m
Enterprise Value £56.1m
Revenue £1.00m
Position in Universe th / 1834
Bullish
Bearish
Unlock SUMM Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

SUMM Revenue Unlock SUMM Revenue

Net Income

SUMM Net Income Unlock SUMM Revenue

Normalised EPS

SUMM Normalised EPS Unlock SUMM Revenue

PE Ratio Range

SUMM PE Ratio Range Unlock SUMM Revenue

Dividend Yield Range

SUMM Dividend Yield Range Unlock SUMM Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
SUMM EPS Forecasts Unlock SUMM Revenue
Profile Summary

Summit Therapeutics plc is a biopharmaceutical company, which is engaged in drug development. The Company is focused on the discovery, development and commercialization of medicines for indications for which there are no existing or only inadequate therapies. It is conducting clinical programs focused on the infectious disease Clostridium difficile infection (CDI). Its lead CDI product candidate is ridinilazole, which is an orally administered small molecule antibiotic. Its Ridinilazole is in Phase II clinical trials. It has conducted over three Phase I clinical trials of ezutromid.

Directors
Last Annual January 31st, 2019
Last Interim October 31st, 2019
Incorporated August 4, 2004
Public Since October 14, 2004
No. of Shareholders: n/a
No. of Employees: 61
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange London Stock Exchange
Shares in Issue 336,159,511
Free Float (0.0%)
Eligible for
ISAs
SIPPs
SUMM Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Similar to SUMM
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.